News | April 28, 2026
Essilor Stellest lens positioned as key breakthrough in myopia control in India
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Move strengthens footprint in Western India and expands multi-specialty care network
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
Cevimeline Hydrochloride Capsules 30mg are indicated for the symptomatic treatment of dry mouth (xerostomia) associated with Sjögren’s syndrome.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
